Z-0814-2022 Class III Terminated
FDA device recall Z-0814-2022 was initiated by Cytocell Ltd. on Feb 4, 2022 and is designated Class III. Reason for recall: May show unexpected locus specific signals in addition to those at 14q32. The recall status is terminated (terminated Nov 6, 2024). Affected quantity: 1 unit.
Recall details
- Product Type
- Devices
- Report Date
- Mar 30, 2022
- Initiation Date
- Feb 4, 2022
- Termination Date
- Nov 6, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1 unit
Product description
TCL1 Breakapart Probe, Fluorescence in situ hybridisation (FISH) is a technique allows the visualisation of DNA sequences upon chromosome Catalog Number: LPH046-A
Reason for recall
May show unexpected locus specific signals in addition to those at 14q32.
Distribution pattern
MN
Code information
Lot 074612
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0814-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026